TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations

Molecular Cancer Therapeutics
Shinichi HasakoKenichi Matsuo

Abstract

Activating mutations in the EGFR gene are important targets in cancer therapy because they are key drivers of non-small cell lung cancer (NSCLC). Although almost all common EGFR mutations, such as exon 19 deletions and the L858R point mutation in exon 21, are sensitive to EGFR-tyrosine kinase inhibitor (TKI) therapies, NSCLC driven by EGFR exon 20 insertion mutations is associated with poor clinical outcomes due to dose-limiting toxicity, demonstrating the need for a novel therapy. TAS6417 is a novel EGFR inhibitor that targets EGFR exon 20 insertion mutations while sparing wild-type (WT) EGFR. In cell viability assays using Ba/F3 cells engineered to express human EGFR, TAS6417 inhibited EGFR with various exon 20 insertion mutations more potently than it inhibited the WT. Western blot analysis revealed that TAS6417 inhibited EGFR phosphorylation and downstream molecules in NSCLC cell lines expressing EGFR exon 20 insertions, resulting in caspase activation. These characteristics led to marked tumor regression in vivo in both a genetically engineered model and in a patient-derived xenograft model. Furthermore, TAS6417 provided a survival benefit with good tolerability in a lung orthotopic implantation mouse model. These findings...Continue Reading

References

Aug 15, 1997·The Biochemical Journal·G M Cohen
Dec 24, 1997·The Journal of Investigative Dermatology·D PeusM R Pittelkow
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Mar 3, 2005·Journal of the National Cancer Institute·Hisayuki ShigematsuAdi F Gazdar
Sep 29, 2005·PLoS Medicine·Heidi GreulichMatthew Meyerson
Sep 23, 2006·Nature Reviews. Cancer·Mario E Lacouture
Aug 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jenn-Yu WuPan-Chyr Yang
Oct 11, 2008·Cell Death and Differentiation·K Balmanno, S J Cook
Aug 21, 2009·The New England Journal of Medicine·Rafael RosellUNKNOWN Spanish Lung Cancer Group
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Dec 7, 2011·Cancer Discovery·Anthony C FaberJeffrey A Engelman
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Jan 19, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Geoffrey R OxnardPasi A Jänne
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Nov 29, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M Beau-FallerJ Cadranel
May 23, 2014·JAMA : the Journal of the American Medical Association·Mark G KrisPaul A Bunn
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Nov 8, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yasushi YatabeTony Mok
Jul 25, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yoshihisa KobayashiTetsuya Mitsudomi
Feb 19, 2016·International Journal of Cancer. Journal International Du Cancer·Mengmeng YangQi-Xiang Li

❮ Previous
Next ❯

Citations

Sep 22, 2020·Expert Opinion on Drug Delivery·Archana UpadhyaAmbikanandan Misra
Mar 12, 2019·Signal Transduction and Targeted Therapy·Simon Vyse, Paul H Huang
May 3, 2019·Proceedings of the National Academy of Sciences of the United States of America·Shinnosuke IkemuraKenzo Soejima
Oct 31, 2020·Current Opinion in Oncology·Lingyun YeFei Zhou
Sep 2, 2020·The American Journal of Surgical Pathology·Takahiro HongoYoshinao Oda
Sep 29, 2019·Seminars in Cancer Biology·Peter T HarrisonPaul H Huang
Nov 18, 2020·International Journal of Molecular Sciences·Jorge Esteban-VillarrubiaJavier Molina-Cerrillo
Sep 27, 2020·Cancer Treatment Reviews·Jordi RemonBenjamin Besse
Mar 18, 2021·Pharmacogenomics and Personalized Medicine·Laura PaciniPaul H Huang
Jul 22, 2020·Chemical Reviews·Richard A WardPaul D Smith
Mar 30, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Rui-Fang DongLing-Yi Kong
Sep 26, 2021·Nature Reviews. Clinical Oncology·Alex FriedlaenderAlfredo Addeo
Dec 17, 2021·Expert Review of Anticancer Therapy·Simon Vyse, Paul H Huang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.